Aseptic Meningitis Complicating Adult Kawasaki Disease:Case Report and Review of the Literature
Am J Med 87:106-110, McIlroy,M.A.,et al, 1989
Indium-111-Labeled Platelet Scintigraphy in Carotid Atherosclerosis
Stroke 20:27-33, Minar,E.,et al, 1989
Sex Difference in Antithrombotic Effect of Aspirin
Stroke 20:34-37, Spranger,M.,et al, 1989
Placebo-Controlled, Randomised Trial of Warfarin & ASA for Prevention of Thromboembolic Complic in Chronic A Fib
Lancet 1:175-179, Petersen,P.,et al, 1989
Management of Carotid Artery Occlusion
Stroke 20:123-126, Cote,R.&Caron,J., 1989
Aspirin for Strokes and Transient Ischaemic Attacks
BMJ 297:995-996, Sandercock,P., 1988
Aspirin All Round
BMJ 296:307-308, Orme,M., 1988
Preliminary Report:Findings from the Aspirin Component of the Ongoing Physicians'Health Study
The Steering Comm. , NEJM 318:262-264, 245-24688., , 1988
Randomized Trial of Prophylactic Daily Aspirin in British Male Doctors
BMJ 296:313-316, Peto,R.,et al, 1988
Secondary Prevention of Vascular Disease by Prolonged Antiplatelet Treatment
Antiplatelet Trailists'Collaboration, BMJ 296:320-3311988., , 1988
Medical Treatment of Transient Ischemic Attacks:Does it Influence Mortality
Stroke 19:397-400, Ramirez-Lassepas,M.&Cipolle,R.J., 1988
Macular Hemorrhage in the Aging Eye:The Effects of Anticoagulants
NEJM 318:1126-1127, Kingham,J.D.,et al, 1988
Reye's Syndrome and Aspirin, Evidence for a Dose-Response Effect
JAMA 260:657-661, Pinsky,P.F.,et al, 1988
High-Dose Acetylsalicylic Acid after Cerebral Infarction
A Swedish Cooperative Study, Stroke 18:325-3341987., , 1987
Public Health Service Study of Reye's Syndrome & Medications, Report of the Main Study
JAMA 257:1905-1911, 19411987., Hurwitz,E.S.,et al, 1987
Single Studies & Overview Analyses:Is Aspirin of Value in Cerebral Ischemia
Stroke 18:541-544, Gent,M., 1987
Clinical Valproate Toxicity Induced by Acetylsalicylic Acid
Neurol 37:1392-1394, Goulden,K.J.,et al, 1987
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
The European Stroke Prevention Study (ESPS) Principal End-Points
The ESPS Group, Lancet 2:1351-13541987., , 1987
Cerebral Ischemia with Mitral Valve Prolapse
Am Heart J 113:1308-1315, Wolf,P.A.,et al, 1987
Aspirin:What Dose? Editorial
Lancet 1:592-593, , 1986
Reye's Syndrome & Aspirin
BMJ 292:1543-1544, 15901986., Tarlow,M., 1986
Magnetic Resonance Imaging in Intractable Partial Epilepsy:Correlative Studies
Ann Neurol 20:57-62, Sperling,M.R.,et al, 1986
No Effect of Acetylsalicylic Acid on B-Thromboglobulin & Platelet Factor 4 Plasma Levels in Patients with TIA's
Stroke 17:1153-1155, Carrieri,P.,et al, 1986
Persantine Aspirin Trial in Cerebral Ischemia Part II:Endpoint Results
The American-Canadian Co-Operative Study Group, Stroke 16:406-4151985., , 1985
Does Platelet Antiaggregant Therapy Lessen the Severity of Stroke
Neurol 35:632-636, Grotta,J.C.,et al, 1985
Naproxen in Prophylaxis of Migraine
Arch Neurol 42:582-584, Ziegler,D.K.,et al, 1985
Public Health Service Study on Reye's Syndrome & Medications, Report of the Pilot Phase
NEJM 313:849-857, Hurwitz,E.S.,et al, 1985
Complex partial Seizures of Frontal Lobe Origin
Ann Neurol 18:497-504, Williamson,P.D.,et al, 1985
Mitral Valve Prolapse & Cerebral Ischemic Events in Young Patients
Neurol 34:784-787, Jackson,A.C.,et al, 1984
Reye's Syndrome Associated with Long-Term Aspirin Therapy
JAMA 251:754-756, Young,R.S.K.,et al, 1984
High-Dose Monotherapy in Treatment of Intractable Seizures
Neurol 34:707-711, Lesser,R.P.,et al, 1984
Therapy of Ischemic Cerebral Vascular Disease Due to Atherothrombosis
NEJM 311:27-34, 100-1051984., Kistler,J.P.,et al, 1984
Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures
Arch Neurol 40:797-802, Rowan,A.J.,et al, 1983
"AICLA"Controlled Trial of Aspirin & Dipyridamole in the Prevention of Athero-Thrombotic Cerebral Ischemia
Stroke 14:5-14, Bousser,M.G.,et al, 1983
Acetylsalicylic Acid in the Prevention of Strokes in Patients with Reversible Cerebral Ischemic Attacks
Stroke 14:15-22, Sorensen,P.S.,et al, 1983
Hepatic & Cerebral Pathology Findings in Children with Fatal Salicylate Intoxication
Lancet 1:326-329, Starko,K.M.,et al, 1983
Treatment after Transient Ischemic Attacks:A Comparison between Anticoagulant Drug & Inhibition of Platelet Aggrega
Stroke 14:677-681, Garde,A.,et al, 1983
Serum Salicylate Concentrations In Reye's Disease
Lancet 1:191-193, Partin,J.S.,et al, 1982
Aspirin as a Risk Factor in Reye's Syndrome
JAMA 247:3089-3094, Waldman,R.J.,et al, 1982
Reye's Syndrome & Medication Use
JAMA 248:687-691, Halpin,T.J.,et al, 1982
Anticoagulant vs Anti-Platelet Therapy as Prophylactic Against Cerebral Infarction in Transient Ischemic Attacks
Stroke 11:4-9, Olsson,J.E.,et al, 1980
Therapy of Ischemic Cerebrovascular Disease
Ann Int Med 93:742-756, Byer,J.A.,et al, 1980
Controversy in Neurology:the Canadian Study on TIA & Aspirin, A Critique
Ann Neurol 6:597-602, Kurtzke,J.F., 1979
Antiplatelet Therapy
NEJM 298:1403, Koch,J., 1978
A Randomized Trial of Aspirin & Sulfinpyrazone in Threatened Stroke
NEJM 299:53, , 1978
Transient Ischemic Attacks & the Prevention of Strokes
NEJM 299:93, Mohr,J.P., 1978
Controlled Trial of Aspirin in Cerebral Ischemia
Stroke 8:301, Fields,W.S.,et al, 1977
Stroke Therapy:Status of Anti-platelet Aggregation Drugs
Neurol 27:503, 1977. (Editorial), Yatsu,F., 1977
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975